BIOMARKER:

EGFR G719A

Entrez ID:

Related biomarkers:

‹

›

EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	gefitinib Sensitive: B - Late Trials	gefitinib Sensitive: B - Late Trials
EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	erlotinib Sensitive: C2 – Inclusion Criteria	erlotinib Sensitive: C2 – Inclusion Criteria
EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	dacomitinib Sensitive: C2 – Inclusion Criteria	dacomitinib Sensitive: C2 – Inclusion Criteria
EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	osimertinib Sensitive: C3 – Early Trials	osimertinib Sensitive: C3 – Early Trials
EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	sintilimab Sensitive: C3 – Early Trials	sintilimab Sensitive: C3 – Early Trials
EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	amivantamab-vmjw Sensitive: C4 – Case Studies	amivantamab-vmjw Sensitive: C4 – Case Studies